From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Unite the historically siloed commercial, financial, and operational aspects of market access to unlock unprecedented operating efficiency, combined with insight into both brand performance and the patient experience.
The only way to ensure the success of our patients and the performance of our drug is to change the way we design, execute, and measure our market access strategy.”
Vice President | Market Access
There’s more innovation in disease treatment and prevention today than maybe at any time in human history. As life sciences continues to evolve to next-generation specialty and precision medicine, the technology supporting market access strategy and decision making has not kept pace.
Too often, manufacturers rely on legacy applications and siloed datasets to support individual access functions.
At IntegriChain, we understand that the most pressing market access challenges — such as improving the patient journey, contract performance management, and gross-to-net predictability — require insights from a wide range of contracting, channel, patient, financial, and pricing data. To overcome the traditional siloed operations of market access found in most manufacturers, IntegriChain has developed a truly unique approach to market access.
Our integrated approach to market access includes:
Market access is designed to accelerate commercialization and get patients access to therapy faster. The function of market access is highly complex and impactful not only on the success of new innovative brands, but on the overall success of the manufacturer.
Regardless of size and complexity, pharmaceutical manufacturers all pursue three core goals:
By using ICyte—the industry’s first truly integrated, purpose-built market access platform—manufacturers can eliminate data integration, data quality, and data wrangling issues. This allows for spending more time analyzing both brand performance and the efficiency of the patient journey.
The power for transforming drug commercialization comes from ICyte’s data unification capabilities. This platform eliminates the silos which have kept payer, channel, and patient data separate. By bringing them together under a common data schema and master data management, higher-value business processes can occur, for example:
The Case for a Market Access Platform Sharing a Platform Vision for Launch Success Improving Market Access Insights and Operations Through Vendor Consolidation
